Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma

摘要

Patient characteristics, tumor and treatment related factors. Differences between the HFRT and NFRT group were evaluated using Fisher’s exact test and the Wilcoxon rank sum test for categorical and continuous variables, respectively. Unknown values were excluded in these tests. KPS: Karnofsky performance status